Molecular Oncology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish contributions novel findings in research to molecular aspects of all types of human cancers. This section ranges from basic sciences to preclinical research. We encourage submission of high-quality manuscripts that provide novel mechanistic insights and details of the molecular signatures of oncogenic transformation. We also encourage submission of high-quality manuscripts that focus on translating basic molecular knowledge to new clinical applications in oncology. The scope of this section includes, but is not limited to, the following:
- Biological processes, like gene activity in relation with specific molecular pathways, in the development and progression of cancers
- Mechanisms of metastasis (vascular and lymphatic dissemination and seeding)
- Molecular interactions in the tumor microenvironment, including tumor-immune interactions
- Genomic profiling of human cancers and any other ‘systems biology’ approaches in understanding development of human cancers
- Preclinical research that leads to novel therapies derived from molecular processes and cellular interactions, including gene therapy, therapy based on biologicals, hormonal therapy, and cancer vaccines and other types of immunotherapies
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Molecular Research in Bone and Soft Tissue Tumors (Deadline: 25 November 2024)
- The Role of RNAs in Cancers: Recent Advances (Deadline: 25 November 2024)
- Molecular Research on Lung Cancer: Translational Perspectives (Deadline: 30 November 2024)
- Estrogen Receptor α-Negative Breast Cancer: Pathology and Genetics for Novel Therapeutic Approaches (Deadline: 30 November 2024)
- The 50th Anniversary of the Discovery of Reciprocal Translocation between Chromosome 9 and 22: The Impact on Molecular and Genomic Knowledge on Cancer (Deadline: 30 November 2024)
- Molecular Biology of the Thyroid Cancer and Thyroid Dysfunctions (Deadline: 30 November 2024)
- Decoding Cancer's Immune Escape: Insights into MHC Class I Antigen Presentation Dysfunction (Deadline: 30 November 2024)
- Molecular Biology of Tumor Cells: Present and Future (Deadline: 30 November 2024)
- Mutant p53 in Cancers (Deadline: 30 November 2024)
- The Occurrence, Evolution and Treatment of Glioblastoma: Second Edition (Deadline: 30 November 2024)
- New Advances in Cancer Stem Cell Research: 2nd Edition (Deadline: 30 November 2024)
- Molecular Research for Cancer Immunotherapy (Deadline: 30 November 2024)
- Preclinical Models for Novel Drug Combination in Advanced Ovarian Cancer (Deadline: 30 November 2024)
- Molecular Insights into Cancer Metabolism, Metastasis, and Immune Evasion (Deadline: 30 November 2024)
- Molecular Mechanism of Leukemogenesis (Deadline: 30 November 2024)
- Neuro-Immune Axis in the Tumor Microenvironment and Cancer Therapy (Deadline: 30 November 2024)
- Molecular Mechanisms of Sarcoma Initiation and Metastasis (Deadline: 30 November 2024)
- The Role of Extracellular Vesicles in Cancers (Deadline: 30 November 2024)
- B Cell Lymphoma: From Pathogenesis to Treatment (Deadline: 30 November 2024)
- Molecular Advances in the Relationship between Diabetes and Cancers (Deadline: 30 November 2024)
- Role of Cancer Stem Cell Regulatory Pathways in Immune Evasion and Drug Resistance (Deadline: 30 November 2024)
- Molecular Advances in Pathology, Diagnosis and Treatment of Gynaecological Cancers (Deadline: 30 November 2024)
- Molecular Mechanism Involved in Cancer Metastasis (Deadline: 30 November 2024)
- Molecular Biology of Cancer—Implications for Diagnosis and Treatment: 2nd Edition (Deadline: 5 December 2024)
- Novel Treatment Strategies for Head and Neck Cancer (Deadline: 15 December 2024)
- Ozone Therapy in Cancer Treatment (Deadline: 20 December 2024)
- The Role of Estrogen and Its Receptors in the Development and Therapy of Cancer (Deadline: 20 December 2024)
- Current Research for Ovarian Cancer Biology and Therapeutics (Deadline: 20 December 2024)
- Inflammation and Cancer 2023 (Deadline: 20 December 2024)
- Advances in Pathogenesis and Treatment of Skin Cancer (Deadline: 20 December 2024)
- Multifaceted Deregulations during Head and Neck Tumorigenesis and Its Application for Cancer Therapeutics (Deadline: 20 December 2024)
- Functional Role of Non-coding RNAs in Cancer: Inside and outside Cells (Deadline: 20 December 2024)
- Emerging Therapeutic Targets for Solid Tumors (Deadline: 20 December 2024)
- miRNAs in Carcinogenesis of Solid and Hematological Malignancies (Deadline: 20 December 2024)
- Cellular Intrinsic Modulators in the Pathogenesis of Cancer and Inflammatory Diseases (Deadline: 20 December 2024)
- The Carcinogenetic Potential of Human Papilloma Virus: From Experimental Studies to Targeted Therapy (Deadline: 20 December 2024)
- Tumor Microenvironment and Non-coding RNAs: Where We Are Now and Where We Are Going To (Deadline: 20 December 2024)
- Epigenetic Dysregulation in Cancers: From Mechanism to Therapy (Deadline: 20 December 2024)
- In Vitro and In Vivo Models of Cancer Progression (Deadline: 20 December 2024)
- Molecular Research on Genitourinary Cancers (Deadline: 20 December 2024)
- Molecular Mechanisms and Therapies of Hematological Tumors (Deadline: 20 December 2024)
- Editorial Board Members’ Collection Series: Nanomedicine in Cancer (Deadline: 20 December 2024)
- Editorial Board Members’ Collection Series: Cancer Metastasis (Deadline: 20 December 2024)
- Molecular Mechanisms in Tumorigenesis of NMSC (Deadline: 20 December 2024)
- Prostate Cancer: From Molecular Diagnosis to Treatment (Deadline: 20 December 2024)
- Precision Cancer Medicine: Molecular Biological Insights, Biological Events and Clinical Perspective (Deadline: 20 December 2024)
- Advances in Proteomics in Cancer (Deadline: 20 December 2024)
- Therapeutic Strategies to Target Cancer Neoantigens (Deadline: 20 December 2024)
- Advances in Tumor Necrosis Factor and Inflammatory Diseases (Deadline: 20 December 2024)
- Molecular Research Targeting Plasma-Cell Myeloma (Deadline: 20 December 2024)
- Molecular Biological Insights and Targeted Therapies for Sarcomas (Deadline: 20 December 2024)
- Molecular Advances in Gynecologic Cancer (Deadline: 20 December 2024)
- Molecular Research on Gynecological Cancers: Ovarian Cancer, Endometrial Cancer, and Gestational Trophoblastic Disease (Deadline: 20 December 2024)
- Molecular Research of Multi-omics in Cancer (Deadline: 20 December 2024)
- New Insights into Radiation Oncology (Deadline: 20 December 2024)
- The Role of Extracellular Matrix in Cancer (Deadline: 20 December 2024)
- Lymphoma: Molecular Pathologies and Therapeutic Strategies (Deadline: 20 December 2024)
- Recent Advances in Breast Cancer Research, 2nd Edition (Deadline: 30 December 2024)
- Novel Biomarkers and Molecular Targets in Gliomas (Deadline: 30 December 2024)
- Liquid Biopsies in Oncology II (Deadline: 31 December 2024)
- Tumor Microenvironments: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression (Deadline: 31 December 2024)
- Breast Cancers: From Molecular Basis to Therapy (Deadline: 31 December 2024)
- State-of-the-Art Molecular Oncology in Brazil, 3rd Edition (Deadline: 31 December 2024)
- Gynecological Cancer 2024 (Deadline: 31 December 2024)
- Roles of Migration and Invasion in Cancer Metastasis (Deadline: 31 December 2024)
- Molecular Mechanism and Treatment of Hemangioma (Deadline: 31 December 2024)
- Breast Cancer: From Pathophysiology to Novel Therapies (Deadline: 31 December 2024)
- Molecular Linkage between Trace Elements and Cancer (Deadline: 31 December 2024)
- New Molecular Aspects of Colorectal Cancer (Deadline: 31 December 2024)
- The Role of Omics in Cancer Diagnosis and Treatment (Deadline: 31 December 2024)
- Advanced Molecular Research of Gynecological Cancer (Deadline: 31 December 2024)
- Molecular Diagnosis and Latest Treatment for Gastric Cancer (Deadline: 31 December 2024)
- Prostate Cancer Research Update: Molecular Diagnostic Biomarkers (Deadline: 31 December 2024)
- Progress in New Agents to Treat Breast Cancer (Deadline: 31 December 2024)
- Role of Cell Metabolism in Cancer Biology (Deadline: 31 December 2024)
- DNA Damage Response from Molecular Mechanisms to Cancer Therapy (Deadline: 31 December 2024)
- Molecular Biology of Lung Cancer: From Intrinsic to Acquired Resistance Mechanisms (Deadline: 31 December 2024)
- Molecular Research on Tumor Suppressor Proteins (Deadline: 31 December 2024)
- Cellular Senescence as a Therapeutic Target in Cancer: Mechanisms, Challenges, and Therapeutic Opportunities (Deadline: 15 January 2025)
- Molecular Mechanisms of Angiogenesis and Cancer (Deadline: 20 January 2025)
- p53 Isoforms and Their Functions in Cancer Studies (Deadline: 20 January 2025)
- Recent Advances in Endometrial Cancer (Deadline: 20 January 2025)
- Aberrations of DNA Repair Pathways in Prostate Cancer 2.0 (Deadline: 20 January 2025)
- Molecular Advances in Cancer Immunotherapy (Deadline: 20 January 2025)
- Discoveries of Genetic Regulations in Onco-Progression (Deadline: 20 January 2025)
- Molecular Pathology and Novel Therapies of Leukemia and Lymphoma (Deadline: 20 January 2025)
- Recent Advances in Anti-Cancer Drugs (Deadline: 20 January 2025)
- Osteosarcoma: Current Advances from Molecular and Cellular Mechanisms to Therapy (Deadline: 20 January 2025)
- New Advances to Overcome Resistance in Tumor Therapy (Deadline: 20 January 2025)
- Recent Advances in Lung Cancer (Deadline: 20 January 2025)
- Current Research for Castration Resistance Prostate Cancer (Deadline: 20 January 2025)
- Circulating Tumor Cells: Pathological, Molecular and Functional Characteristics 4.0 (Deadline: 20 January 2025)
- Epigenetics and Immunotherapy in Cancer (Deadline: 20 January 2025)
- Trends and Prospects in Electroporation-Based Treatment for Tumors (Deadline: 20 January 2025)
- Recent Advances in Brain Cancers (Deadline: 20 January 2025)
- Update on Immunotherapies for Cancer (Deadline: 20 January 2025)
- Metals and Cancer (Deadline: 20 January 2025)
- Recent Advances in Cancer Biomarkers, Artificial Intelligence and Emerging Technologies (Deadline: 20 January 2025)
- Molecular Diagnostic Strategies for Prediction and Prognosis of Gastric Cancer (Deadline: 20 January 2025)
- Innovative Approaches for Targeted Cancer Therapies (Deadline: 20 January 2025)
- Liquid Biopsy in the Approach of Non-communicable Chronic Diseases (NCCD) and Cancer (Deadline: 20 January 2025)
- Intratumor Heterogeneity and Therapy Resistance of Solid Tumors: Treacherous Apoptosis, Reversible Senescence, Genome Chaos, and More (Deadline: 20 January 2025)
- NK Cells, Immune Response in Pathology and Cancer, 2nd Edition (Deadline: 20 January 2025)
- Molecular Insights into Epigenetics in Cancer (Deadline: 20 January 2025)
- Non-small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 20 January 2025)
- Tumor Microenvironment in Cancer Cell Metastasis (Deadline: 20 January 2025)
- Genomic Oncology and Medicine in Leukemia: From Molecular Pathogenesis to Novel Therapeutic Approaches (Deadline: 20 January 2025)
- Advances and Mechanisms in Breast Cancer (Deadline: 20 January 2025)
- Signaling Pathways Dysregulation in Cancer: Advances and New Therapeutics Hopes (Deadline: 20 January 2025)
- Advances in Head and Neck and Skin Cancer (Deadline: 20 January 2025)
- Melatonin and Vitamins: New Insights into Cancer Therapies (Deadline: 20 January 2025)
- New Aspects of Bioenergetics in Cancer (Deadline: 20 January 2025)
- From Bench to Bedside: A Triad of Innovation in Gastric Cancer Treatment—Immunotherapies, Gene Therapy and Surgery Unite (Deadline: 20 January 2025)
- Cancer Cell Metabolism: New Advances and Potential Therapies (Deadline: 20 January 2025)
- Advancements in Understanding Protein Misfolding Disorders and Cancer (Deadline: 20 January 2025)
- Editorial Board Members’ Collection Series: Cancer Metabolism (Deadline: 20 January 2025)
- Cancer: Molecular Research and Novel Inflammatory Targets (Deadline: 20 January 2025)
- Integrative Multi-Omics Analysis for Cancer Biomarkers (Deadline: 20 January 2025)
- Molecular Biology and Targeted Therapies in Leukemias (Deadline: 20 January 2025)
- Molecular Targeted Therapy for Gliomas (Deadline: 20 January 2025)
- Novel Therapeutic Targets in Cancers: 3rd Edition (Deadline: 20 January 2025)
- Molecular Regulation Mechanisms of Tumor Progression: State-of-the-Art and Future Perspectives (Deadline: 20 January 2025)
- Biomarkers of Tumor Progression, Prognosis and Therapy: 2nd Edition (Deadline: 20 January 2025)
- Insights into Chronic Liver Disease and Hepatocellular Carcinoma (Deadline: 20 January 2025)
- Molecular Genetics of Breast Cancer—Recent Progress (Deadline: 20 January 2025)
- Advanced Research on Biomarkers in Gastrointestinal Cancer: 2nd Edition (Deadline: 20 January 2025)
- Colorectal Cancer: Molecular Mechanism and Treatment Strategies (Deadline: 20 January 2025)
- Molecular Mechanisms Underlying Metastatic Potential in Cancer (Deadline: 20 January 2025)
- Role of the Epithelial Mesenchymal Transition in Cancer Development and Invasiveness (Deadline: 20 January 2025)
- Prostate Cancer: Molecular Biology, Prognostication and Treatment Approaches (Deadline: 20 January 2025)
- Molecular Mechanisms and Therapeutic Strategies to Overcome Drug Resistance in Cancer (Deadline: 30 January 2025)
- Innovative Technologies in the Study and Understanding of Colorectal Tumorigenesis: Challenges and Opportunities (Deadline: 30 January 2025)
- Novel Therapeutic Advances in Pancreatic Cancer (Deadline: 30 January 2025)
- From Diagnosis to Treatment of Haematological Neoplasms (Deadline: 31 January 2025)
- Molecular Mechanisms of Tumorigenesis of Human and Animal Stem Cells (Deadline: 31 January 2025)
- New Molecular Mechanisms in the Development of Brain Tumors and Metastases (Deadline: 31 January 2025)
- Molecular Research and Cellular Biology of Breast Cancer (Deadline: 31 January 2025)
- Squamous Cell Carcinoma: From Molecular Mechanisms to Therapeutics (Deadline: 31 January 2025)
- Molecular Insights into the Precision Medicine on Neoplastic Diseases: Challenges, Perspectives and Opportunities (Deadline: 31 January 2025)
- KRAS-Mutant Cancers: From Basic Biology to Clinical Translation (Deadline: 31 January 2025)
- Molecular and Translational Research of Non-Small Cell Lung Cancer (Deadline: 31 January 2025)
- Recent Advances in Head and Neck Cancers (Deadline: 31 January 2025)
- Insights into the Pathogenesis, Molecular Landscape and Therapeutics of Triple-Negative Breast Cancer (Deadline: 31 January 2025)
- Molecular Biology and Targeted Therapies of the Brain Tumors (Deadline: 20 February 2025)
- Disorders of Alcohol Metabolism in the Occurrence and Development of Cancer (Deadline: 20 February 2025)
- The Transcriptome Complexity in Cancer and Leukemia: Alternative Splicing and Beyond (Deadline: 20 February 2025)
- Role of MicroRNAs in Cancer Development and Treatment, 2nd Edition (Deadline: 20 February 2025)
- Molecular Mechanism of Cancer Research and Therapies (Deadline: 20 February 2025)
- Current and Future Roles of Tumor Markers in Prostate Adenocarcinoma (Deadline: 20 February 2025)
- Current Advances in Diagnostic and Therapeutic Approaches for Gastric Cancer (Deadline: 20 February 2025)
- New Insights into the Pathobiology of T Cell Malignancies (Deadline: 20 February 2025)
- Immunotherapy in Tumors: Treatments, Complications and Diagnostic Evaluation of Response (Deadline: 20 February 2025)
- Antibody Therapy for Hematologic Malignancies (Deadline: 20 February 2025)
- Molecular Mechanisms and Immunotherapy of Soft Tissue and Bone Sarcomas (Deadline: 20 February 2025)
- Combating Drug Resistance in Cancer: From Novel Biomarkers to Enhanced Therapeutic Efficacy—2nd Edition (Deadline: 20 February 2025)
- Glioblastoma: State of the Art and Future Trends (Deadline: 20 February 2025)
- Recent Insights into Colorectal Cancer Treatment (Deadline: 20 February 2025)
- Advances and Perspectives in Molecular Tumor Therapy (Deadline: 20 February 2025)
- Molecular Basis of Odontogenic Tumors and Odontogenic Cysts (Deadline: 20 February 2025)
- Advances in the Diagnosis and Treatment of Non-small Cell Lung Cancer (Deadline: 20 February 2025)
- Molecular Research on Oral Cancer (Deadline: 20 February 2025)
- Epigenetic Genes, Biomarkers and Immunotherapy in Cancers (Deadline: 20 February 2025)
- NF-κB and Cancer 2.0 (Deadline: 20 February 2025)
- Immunotherapy versus Immune Modulation of Leukemia (Deadline: 20 February 2025)
- Advanced Research on Obesity and Cancer (Deadline: 20 February 2025)
- Oncoprotein Mechanisms: Prospects in Treatment (Deadline: 20 February 2025)
- The Roles of Photodynamic Therapy in Tumors and Cancers (Deadline: 20 February 2025)
- Advances in Lung Cancer: From Genetic Landscape to Treatment (Deadline: 20 February 2025)
- Molecular Biology on Cancer Genomics (Deadline: 20 February 2025)
- Biomarkers, Treatments, and Clinical Outcomes for Meningiomas and Other Skull Base Tumors (Deadline: 20 February 2025)
- Molecular Diagnostics and Genomics of Tumors (Deadline: 20 February 2025)
- Leukemia and Lymphoma: A Focus on Molecular Genetics Research (Deadline: 20 February 2025)
- Cell Apoptosis in Cancers: Regulation Factors (Deadline: 20 February 2025)
- The Role of Extracellular Vesicles in Cancer Diagnosis and Therapy, 2nd Edition (Deadline: 20 February 2025)
- Brain Tumors: From Biomarkers to Novel Therapies (Deadline: 20 February 2025)
- Unveiling the Molecular Landscape Through Next-Generation Liquid Biopsy (Deadline: 20 February 2025)
- Targeted Radioligand Therapy and Immunotherapy for Cancer Treatment (Deadline: 20 February 2025)
- Advances and Insights in Tumorogenesis and Tumor Metastasis (Deadline: 20 February 2025)
- Challenges and Future Perspectives in Treatment for Lung Cancer (Deadline: 20 February 2025)
- Molecular Mechanisms and Therapies of Brain Tumors (Deadline: 20 February 2025)
- Gynecological Oncology: From Molecular Basis to Therapy (Deadline: 20 February 2025)
- Tumor Microenvironment and Drug Resistance (Deadline: 26 February 2025)
- Navigating Precision Oncology: Integrating Biomarkers into Clinical Practice (Deadline: 28 February 2025)
- Glioblastoma: From Molecular Mechanisms to Therapies (Deadline: 28 February 2025)
- Mitochondria as a Therapeutic Target for Anti-cancer Drugs (Deadline: 28 February 2025)
- Genetic Considerations in the Evolving Treatment Landscape of Hormone-Sensitive and Hormone-Resistant Prostate Cancer (Deadline: 28 February 2025)
- Tumor Microenvironment and Cancer Progression: Molecular Insights for Targeted Therapy (Deadline: 28 February 2025)
- Molecular Pathology and Treatment of Ovarian Cancer (Deadline: 28 February 2025)
- Molecular Biology and Diagnosis on Biliary and Pancreatic Cancers (Deadline: 28 February 2025)
- Epigenetic Mechanisms in Cancer Biology (Deadline: 28 February 2025)
- Molecular Mechanisms and Novel Therapies for Colon Cancer (Deadline: 28 February 2025)
- Advances in Gynecological Cancers—3rd Edition (Deadline: 28 February 2025)
- Recent Advances and Challenges in Colorectal Cancer: From Molecular Research to Treatment (Deadline: 28 February 2025)
- Advances in Melanoma and Skin Cancers: 2nd Edition (Deadline: 28 February 2025)
- Recent Advances in Molecular Targets for Treatment and Drug Delivery in Tumors (Deadline: 28 February 2025)
- Obesity and Cancer Risk: Molecular Mechanisms and Perspectives (Deadline: 28 February 2025)
- Advances in Molecular Research on Cancer Treatments (Deadline: 28 February 2025)
- Metastasis: Mechanisms, Models, and Therapeutic Advances (Deadline: 28 February 2025)
- Nanoparticle Systems for Cancer Phototherapy (Deadline: 28 February 2025)
- Glioma: Molecular Mechanisms and Therapeutic Strategies (Deadline: 28 February 2025)
- Oral Squamous Cell Carcinoma: Insights into Molecular Pathways and Emerging Therapeutic Approaches (Deadline: 28 February 2025)
- Circulating Cell-Free Nucleic Acids and Cancers: 2nd Edition (Deadline: 20 March 2025)
- Current Research on Cancer Drug Resistance (Deadline: 20 March 2025)
- Advances in Immunotherapy for Cancer: From Molecular Basis to Novel Biomarkers and Therapeutic Targets (Deadline: 20 March 2025)
- Renal Cell Carcinoma: Novel Insights into Pathophysiology, Diagnosis and Therapy (Deadline: 20 March 2025)
- Lung Cancer: From Molecular Mechanisms to Novel Therapeutics (Deadline: 20 March 2025)
- Molecular Research of Natural Products in Cancer Diseases (Deadline: 20 March 2025)
- Molecular Insight into Leukemia (Deadline: 20 March 2025)
- The Emerging Role of Neutrophils in Cancer: Molecular Aspects of Plasticity and Potential Therapeutic Targets (Deadline: 20 March 2025)
- Targeted Therapy and Molecular Strategies for Gynecological Cancer (Deadline: 20 March 2025)
- Cancer-Related Biochemical Pathways: From Tumor Outgrowth, Metastasis to Novel Targeted Therapy (Deadline: 20 March 2025)
- The Hallmarks of Cancer Stem Cells (Deadline: 20 March 2025)
- Cancer Immunotherapy: Tumor Microenvironment, Biomarker Discovery and Immune Resistance: 2nd Edition (Deadline: 20 March 2025)
- Predictive, Prognostic Biomarkers and Therapeutic Targets of Breast Cancer (Deadline: 20 March 2025)
- New Diagnostic Tools and Biomarkers in Oncological Diseases: 2nd Edition (Deadline: 20 March 2025)
- Gastrointestinal Cancer: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 20 March 2025)
- Pituitary Tumors: An Update in the Pathogenetic Mechanisms, the Diagnostic Methods and the Therapeutic Approaches (Deadline: 20 March 2025)
- Pathogenesis and Molecular Treatment of Primary Liver Cancer (Deadline: 20 March 2025)
- Molecular and Therapeutic Advanced Research in Prostate Cancer (Deadline: 20 March 2025)
- Molecular Insights into Glioblastoma Pathogenesis: Focus on Progenitor Cells, Microglia and Noncoding RNA (Deadline: 20 March 2025)
- New Molecular Advances in Lung Cancer (Deadline: 20 March 2025)
- Molecular Mechanisms Underlying Pancreatic Cancer Progression and Drug Resistance (Deadline: 20 March 2025)
- Microbiota and Cancer: 4th Edition (Deadline: 20 March 2025)
- The Role of Hormonal Receptors in Cancer: Molecular Mechanisms and Targeted Therapies (Deadline: 20 March 2025)
- Novel Insights into Myeloid Neoplasms: From Pathogenesis to Targeted Therapies (Deadline: 20 March 2025)
- Advances in the Molecular Diagnosis and Treatment of Pancreatic Cancer (Deadline: 20 March 2025)
- Biomarkers and Early Detection Strategies of Ovarian Tumors (Deadline: 20 March 2025)
- Mitochondrial Respiration and Energy Metabolism in Cancer Cells (Deadline: 20 March 2025)
- Molecular Pathology and Novel Therapies for Lymphoma (Deadline: 20 March 2025)
- Molecular Advances in Endometrial Cancer (Deadline: 20 March 2025)
- Molecular Basis and Advances of Targeted Therapy for Breast Cancer: Second Edition (Deadline: 20 March 2025)
- Molecular Mechanism and Therapeutic Approaches of Breast Cancer, Metastatic Breast Cancer, 3rd Edition (Deadline: 20 March 2025)
- Research on Signal Transduction Mechanisms of Cancer Cells (Deadline: 28 March 2025)
- Molecular Insights and Innovations in Brain Cancer Research (Deadline: 30 March 2025)
- Novel Combination Therapies for the Solid Cancers Treatment (Deadline: 30 March 2025)
- Current Research on Cancer Biology and Therapeutics: Third Edition (Deadline: 30 March 2025)
- Systemic and Mucosal Inflammation in Colorectal Cancer: Underlying Factors, Significance, and Related Biomarkers, 2nd Edition (Deadline: 30 March 2025)
- Molecular Research on Tumor Metastasis and Inhibition (Deadline: 30 March 2025)
- Mechanisms Underlying Cancer Chemoresistance: A Starting Point to Identify New Anticancer Strategies (Deadline: 31 March 2025)
- Gynecologic Cancer: From Molecular, Cellular Mechanisms to Novel Therapies (Deadline: 31 March 2025)
- New Advances in Molecular Research in Leukemia (Deadline: 31 March 2025)
- Chronic Liver Disease and Hepatocellular Carcinoma—2nd Edition (Deadline: 31 March 2025)
- Phenotypes to Genotypes: Breaking the Chains of EGFR Addiction in Lung Cancer (Deadline: 31 March 2025)
- Novel Concepts in Drug Delivery in Cancer Therapy (Deadline: 31 March 2025)
- Advances in Cancer Stem Cells and Tumor Microenvironment (Deadline: 31 March 2025)
- Cutting-Edge Research for Cancer Stem Cells (Deadline: 31 March 2025)
- Resistance to Therapy in Ovarian Cancers (Deadline: 20 April 2025)
- New Molecular Mechanisms and Advanced Therapies for Solid Tumors (Deadline: 20 April 2025)
- Cancer Genomics (Deadline: 20 April 2025)
- Hormone Signaling in Cancers and Cancer-Promoting Pathologies (Deadline: 20 April 2025)
- Molecular Research and Treatment of Prostate Cancer (Deadline: 20 April 2025)
- Viral Infections and Cancer: Recent Advances and Future Perspectives (Deadline: 20 April 2025)
- Mesenchymal Stem Cells and Cancer (Deadline: 20 April 2025)
- New Advances in B-cell Lymphoma Biology (Deadline: 20 April 2025)
- Molecular Mechanisms of Tumor Progression and New Therapeutic Strategies for Urological Cancers, 2nd Edition (Deadline: 20 April 2025)
- Recent Advances in Cancer Chemoprevention: Focus on Natural Product (Deadline: 20 April 2025)
- The Role of Macrophages in Cancers (Deadline: 20 April 2025)
- Liver Cancer 3.0 (Deadline: 20 April 2025)
- Molecular Aspects of Adrenal Diseases and Carcinoma (Deadline: 20 April 2025)
- Genomics and Proteomics of Cancer (Deadline: 20 April 2025)
- Latest Progress in Cancer Cell Communications (Deadline: 20 April 2025)
- Editorial Board Members’ Collection Series: Genetic and Molecular Intricacies Underlying Brain Tumors (Deadline: 20 April 2025)
- Recent Advances in Gastrointestinal Cancer, 2nd Edition (Deadline: 20 April 2025)
- Metabolomics in Oncology (Deadline: 20 April 2025)
- Recent Developments in Omics Technologies Applied to Oncology Research (Deadline: 20 April 2025)
- Novel Therapeutic Strategies for Gynecological Cancer: Molecular Biological Insights (Deadline: 20 April 2025)
- Reproduction and Cancer: Cell-Cell Interaction and Signal Transduction (Deadline: 20 April 2025)
- The Discovery and Characterization of New Oncological Molecules (Deadline: 20 April 2025)
- Therapeutic Targets in Pancreatic Cancer: 2nd Edition (Deadline: 20 April 2025)
- Recent Advances in Gastrointestinal Tract Oncology: Pathology, Diagnostics and Therapy (Deadline: 20 April 2025)
- Molecular, Translational and Clinical Research of Cancer Structural Biomarkers (Deadline: 20 April 2025)
- Mechanistic Insights into Cancer Immunotherapy and Immune-Related Adverse Events (Deadline: 20 April 2025)
- Translational Oncology: From Molecular Basis to Therapy (Deadline: 20 April 2025)
- Ovarian Cancer: Advances on Pathophysiology and Therapies (2nd Edition) (Deadline: 20 April 2025)
- Defeating Multidrug Resistance: Innovations in Cancer Therapy (Deadline: 20 April 2025)
- Wnt/β-Catenin Signaling in Cancer (Deadline: 20 April 2025)
- Exploring Novel Molecular, Metabolic and Cellular Mechanisms for Developing New Therapeutic Targets Against Childhood Cancers, 2nd Edition (Deadline: 20 April 2025)
- Genomic Research in Carcinogenesis, Cancer Progression and Recurrence (Deadline: 20 April 2025)
- Cutting-Edge Advances in New Anticancer Agents: Design, Synthesis and Application (Deadline: 20 April 2025)
- Targeted Therapies and Molecular Methods in Cancer, 3rd Edition (Deadline: 20 April 2025)
- Peptide Receptor Radionuclide Therapy (PRRT) and Targeted Alpha Therapy (TAT) in Cancer (Deadline: 29 April 2025)
- Exploring Markers and Molecular Pathogenesis of Cancer: Genitourinary and Gynecological Tumors (Deadline: 30 April 2025)
- Tumor Angiogenesis and Metastasis: From Molecular Signalling to Therapeutic Approaches (Deadline: 30 April 2025)
- TGF-β Signaling in Immunity, Inflammation, Fibrosis and Cancer (Deadline: 30 April 2025)
- Urothelial Cancer: From Translational Medicine to Recent Innovations in Therapeutic Management (Deadline: 30 April 2025)
- Biological Hallmarks and Therapeutic Strategies in Cancer (Deadline: 30 April 2025)
- Molecular Targets and Mechanisms of Innovative Therapies and Natural Adjuvants in Glioblastoma Management (Deadline: 30 April 2025)
- Recent Advances in Molecular Mechanisms of Human Papillomavirus Family (HPV) Induced Oncogenesis (Deadline: 20 May 2025)
- Pathogenesis and Treatments of Head and Neck Cancer (Deadline: 20 May 2025)
- Role of p53 Family in Targeted Therapy of Cancers (Deadline: 20 May 2025)
- Role of Mitochondria in Cancer (Deadline: 20 May 2025)
- Cancer Biology: From Genetic Aspects to Treatment (Deadline: 20 May 2025)
- Molecular Research and Treatment of Breast Cancer: 3rd Edition (Deadline: 20 May 2025)
- Fibrosis in Inflammation and Cancer (Deadline: 20 May 2025)
- Growth Hormone Tumor: Molecular Pathologies, Diagnosis, and Therapeutic Strategies (Deadline: 20 May 2025)
- Latest Review Papers in Molecular Oncology 2024 (Deadline: 20 May 2025)
- Small Cell Lung Cancer Entering the Sphere of Personalized Treatment (Deadline: 20 May 2025)
- Melanoma: Molecular Mechanisms and Therapy (Deadline: 20 May 2025)
- Molecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition (Deadline: 20 May 2025)
- Recent Trends in Experimental Models for Cancer Research (Deadline: 20 May 2025)
- Histopathological and Cytological Biomarkers for Breast and Gynecologic Cancers (Deadline: 20 May 2025)
- Deciphering Molecular Complexity of Pancreatic Cancer (Deadline: 20 May 2025)
- Bioactive Compounds and Enzyme Inhibitors in Cancer Therapy (Deadline: 20 May 2025)
- Bacteria-Mediated Cancer Therapy: New Molecular Insights (Deadline: 27 May 2025)
- Molecular Mechanisms and Therapies of Colorectal Cancer: 4th Edition (Deadline: 31 May 2025)
- Novel Molecular Pathways in Oncology, 3rd Edition (Deadline: 31 May 2025)
- Molecular and Cellular Mechanisms of Pancreatic Cancer (Deadline: 20 June 2025)
- Molecular Research on the Pancreatic Cancer (Deadline: 20 June 2025)
- The Multiple Faces of Non-small Cell Lung Cancer: Targeted Therapies and Recent Developments (Deadline: 20 June 2025)
- Towards Complex Molecular Cancer Therapies (Deadline: 20 August 2025)
Topical Collections
Following topical collections within this section are currently open for submissions: